Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Longnecker

Showing results (91-100 of 151) with videos related to

Pageof 16
Sort By:
Structure (London, England : 1993)|February 17, 2009
Structure of Epstein-Barr virus glycoprotein 42 suggests a mechanism for triggering receptor-activated virus entryAustin N Kirschner, Jessica Sorem, Richard Longnecker, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2003
Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseasesMichelle Swanson-Mungerson, Masato Ikeda, Lori Lev, et al.
Nature Reviews. Microbiology|April 12, 2011
Fusing structure and function: a structural view of the herpesvirus entry machinerySarah A Connolly, Julia O Jackson, Theodore S Jardetzky, et al.
Molecular Cell|February 28, 2002
Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1Maureen M Mullen, Keith M Haan, Richard Longnecker, et al.
Virus Genes|February 18, 2010
Characteristics of Epstein-Barr virus envelope protein gp42Pamela L Shaw, Austin N Kirschner, Theodore S Jardetzky, et al.
Virology|March 8, 2011
Mapping regions of Epstein-Barr virus (EBV) glycoprotein B (gB) important for fusion function with gH/gLAileen E Plate, Jessica J Reimer, Theodore S Jardetzky, et al.
Cell Cycle (Georgetown, Tex.)|February 18, 2010
Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2AKathryn T Bieging, Michelle Swanson-Mungerson, Alexandra C Amick, et al.
Journal of Virology|May 28, 2005
Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigenMichelle A Swanson-Mungerson, Robert G Caldwell, Rebecca Bultema, et al.
Mbio|February 21, 2019
Ephrin Receptor A4 is a New Kaposi's Sarcoma-Associated Herpesvirus Virus Entry ReceptorJia Chen, Xianming Zhang, Samantha Schaller, et al.
The Journal of Biological Chemistry|December 26, 2001
Signal transduction through the B cell antigen receptor is normal in ataxia-telangiectasia B lymphocytesPeter Speck, Masato Ikeda, Akiko Ikeda, et al.
Pageof 16

Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Structure (London, England : 1993)|February 17, 2009
Structure of Epstein-Barr virus glycoprotein 42 suggests a mechanism for triggering receptor-activated virus entryAustin N Kirschner, Jessica Sorem, Richard Longnecker, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2003
Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseasesMichelle Swanson-Mungerson, Masato Ikeda, Lori Lev, et al.
Nature Reviews. Microbiology|April 12, 2011
Fusing structure and function: a structural view of the herpesvirus entry machinerySarah A Connolly, Julia O Jackson, Theodore S Jardetzky, et al.
Molecular Cell|February 28, 2002
Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1Maureen M Mullen, Keith M Haan, Richard Longnecker, et al.
Virus Genes|February 18, 2010
Characteristics of Epstein-Barr virus envelope protein gp42Pamela L Shaw, Austin N Kirschner, Theodore S Jardetzky, et al.
Virology|March 8, 2011
Mapping regions of Epstein-Barr virus (EBV) glycoprotein B (gB) important for fusion function with gH/gLAileen E Plate, Jessica J Reimer, Theodore S Jardetzky, et al.
Cell Cycle (Georgetown, Tex.)|February 18, 2010
Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2AKathryn T Bieging, Michelle Swanson-Mungerson, Alexandra C Amick, et al.
Journal of Virology|May 28, 2005
Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigenMichelle A Swanson-Mungerson, Robert G Caldwell, Rebecca Bultema, et al.
Mbio|February 21, 2019
Ephrin Receptor A4 is a New Kaposi's Sarcoma-Associated Herpesvirus Virus Entry ReceptorJia Chen, Xianming Zhang, Samantha Schaller, et al.
The Journal of Biological Chemistry|December 26, 2001
Signal transduction through the B cell antigen receptor is normal in ataxia-telangiectasia B lymphocytesPeter Speck, Masato Ikeda, Akiko Ikeda, et al.
Pageof 16